{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:40:21Z","timestamp":1772232021933,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hypopituitarism has been associated with increased mortality. The excess mortality may be due to untreated growth hormone (GH) deficiency but also due to various underlying disorders. We therefore analysed mortality in patients with only one underlying disorder, non-functioning pituitary adenoma (NFPA), with and without GH replacement therapy (GHRT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and method<\/jats:title>\n                    <jats:p>Patients with NFPA in the western region of Sweden, 1997\u20132011, were identified through the National Patient Registry and cross-referenced with several National Health Registries. All patient records were reviewed. Standardised mortality ratios (SMRs) with 95% confidence intervals (CIs) were calculated using the general population as reference. Cox-regression models were performed to identify predictors of mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 426 NFPA patients with 4599 patient-years were included, of whom 207 had used GHRT and 219 had not received GHRT. Median (range) follow-up in patients with and without GHRT was 12.2 (0\u201325) and 8.2 (0\u201327) years, respectively. Other pituitary hormone deficiencies were more frequent in the GHRT group than those in the non-GHRT group. SMR was 0.65 (95% CI, 0.44\u20130.94;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.018) for the GHRT group and 1.16 (0.94\u20131.42;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.17) for the non-GHRT group. Direct comparison between the groups showed reduced mortality among those who were GH replaced (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0063). The SMR for malignant tumours was reduced in the GHRT-group (0.29; 0.08\u20130.73;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004) but not in untreated patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Selection bias explaining some of the results cannot be excluded. However, NFPA patients with GHRT had reduced overall mortality compared with the general population, and death due to malignancy was not increased. This suggests that long-term GHRT is safe in adult patients selected for treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-16-0450","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T23:48:39Z","timestamp":1477093719000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":39,"title":["Life expectancy in patients with pituitary adenoma receiving growth hormone replacement"],"prefix":"10.1093","volume":"176","author":[{"given":"Daniel S","family":"Olsson","sequence":"first","affiliation":[{"name":"1Department of EndocrinologyInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Trimpou","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Hall\u00e9n","sequence":"additional","affiliation":[{"name":"2Department of NeurosurgerySahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ing-Liss","family":"Bryngelsson","sequence":"additional","affiliation":[{"name":"3Department of Occupational and Environmental Medicine\u00d6rebro University Hospital, \u00d6rebro, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Andersson","sequence":"additional","affiliation":[{"name":"4Department of Occupational and Environmental MedicineSahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Skoglund","sequence":"additional","affiliation":[{"name":"2Department of NeurosurgerySahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt-\u00c5ke","family":"Bengtsson","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna G","family":"Nilsson","sequence":"additional","affiliation":[{"name":"1Department of EndocrinologyInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, G\u00f6teborg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2016111418002119000_176.1.67.1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.beem.2009.05.005","article-title":"Non-functioning pituitary adenomas","volume":"23","author":"Greenman","year":"2009","journal-title":"Best Practice and Research Clinical Endocrinology and Metabolism"},{"key":"2016111418002119000_176.1.67.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1420"},{"key":"2016111418002119000_176.1.67.3","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1210\/jc.2015-1475","article-title":"Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish nationwide study","volume":"100","author":"Olsson","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002119000_176.1.67.4","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91812-O"},{"key":"2016111418002119000_176.1.67.5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x"},{"key":"2016111418002119000_176.1.67.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04006-X"},{"key":"2016111418002119000_176.1.67.7","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-1028"},{"key":"2016111418002119000_176.1.67.8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4059"},{"key":"2016111418002119000_176.1.67.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1215"},{"key":"2016111418002119000_176.1.67.10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2684"},{"key":"2016111418002119000_176.1.67.11","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2014-1814","article-title":"Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency","volume":"99","author":"Stochholm","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2016111418002119000_176.1.67.12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3787"},{"key":"2016111418002119000_176.1.67.13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/cen.12848","article-title":"Growth hormone replacement does not increase mortality in patients with childhood-onset growth hormone deficiency","volume":"83","author":"Berglund","year":"2015","journal-title":"Clinical Endocrinology"},{"key":"2016111418002119000_176.1.67.14","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0631"},{"key":"2016111418002119000_176.1.67.15","unstructured":"Johansson LA . D\u00f6dsorsaksstatistik \u2013 Historik, Produktionsmetoder och Tillf\u00f6rlitlighet, p 38. The National Board of Health and Welfare webpage, 2010."},{"key":"2016111418002119000_176.1.67.16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"2016111418002119000_176.1.67.17","doi-asserted-by":"publisher","DOI":"10.1080\/02841860802247664"},{"key":"2016111418002119000_176.1.67.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7382.219"},{"key":"2016111418002119000_176.1.67.19","unstructured":"Cantor AB. SAS Survival Analysis Techniques for Medical Research, Second Edition. Cary, NC, USA: SAS Institute Inc., 2003."},{"key":"2016111418002119000_176.1.67.20","first-page":"62","article-title":"Effects of growth hormone on fat mass and fat distribution","volume":"383","author":"Bengtsson","year":"1992","journal-title":"Acta Paediatrica Supplement"},{"key":"2016111418002119000_176.1.67.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.12.3585"},{"key":"2016111418002119000_176.1.67.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1487"},{"key":"2016111418002119000_176.1.67.23","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-1088"},{"key":"2016111418002119000_176.1.67.24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ghir.2008.05.005","article-title":"Role of the GH\/IGF-1 axis in lifespan and healthspan: lessons from animal models","volume":"18","author":"Berryman","year":"2008","journal-title":"Growth Hormone and IGF Research"},{"key":"2016111418002119000_176.1.67.25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ghir.2008.09.002","article-title":"The aging population \u2013 is there a role for endocrine interventions?","volume":"19","author":"Nass","year":"2009","journal-title":"Growth Hormone and IGF Research"},{"key":"2016111418002119000_176.1.67.26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nrendo.2013.67","article-title":"The GH\/IGF-1 axis in ageing and longevity","volume":"9","author":"Junnila","year":"2013","journal-title":"Nature Reviews Endocrinology"},{"key":"2016111418002119000_176.1.67.27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/MED.0b013e328363183a","article-title":"Growth hormone and cancer: an update on progress","volume":"20","author":"Perry","year":"2013","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"2016111418002119000_176.1.67.28","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2536"},{"key":"2016111418002119000_176.1.67.29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth hormone, the insulin-like growth factor axis, insulin and cancer risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nature Reviews Endocrinology"},{"key":"2016111418002119000_176.1.67.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16044-3"},{"key":"2016111418002119000_176.1.67.31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2394"},{"key":"2016111418002119000_176.1.67.32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/jc.2014-3525","article-title":"Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in sweden","volume":"100","author":"Olsson","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/1\/67.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/1\/67.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:34:22Z","timestamp":1676374462000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/176\/1\/67\/6655000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/eje-16-0450","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726872199.793538658","asserted-by":"object"}]},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}